Search results for "Ulcerative"

showing 10 items of 294 documents

Endoscopic confocal imaging.

2005

In vivo fluorescence endomicroscopy is a newly developed diagnostic tool enabling virtual in vivo histology of the mucosal layer during ongoing endoscopy. This review summarizes currently available data about the technique and clinical use of confocal endomicroscopy. Indications discussed include colorectal cancer evaluation, ulcerative colitis and surveillance, Barrett's esophagus, and detection of Helicobacter pylori infection in vivo.

Diagnostic ImagingPathologymedicine.medical_specialtyColorectal cancerGastrointestinal DiseasesConfocalEndoscopy GastrointestinalDiagnosis DifferentialConfocal imagingIn vivoEndomicroscopyMedicineHumansEsophagusIntestinal MucosaMicroscopy ConfocalHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsEquipment Designmedicine.diseaseUlcerative colitisdigestive system diseasesEndoscopymedicine.anatomical_structurebusinessClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Imaging techniques in inflammatory bowel disease: recent trends, questions and answers

2009

Summary Imaging techniques have undergone substantial progress in recent years and contribute significantly in the diagnosis of inflammatory bowel diseases in conjunction with patient history, clinical and laboratory examination. Modern cross-sectional imaging modalities such as computed tomography and magnetic resonance imaging allow an evaluation not only of the complete bowel wall of the small intestine, but also of extraluminal structures. They constitute a major diagnostic component in the initial workup, in stricturing or fistulizing disease and in suspected abscess. Transabdominal ultrasonography has been re-appreciated in these settings as an easy- and ready-to-use tool yielding rea…

Diagnostic Imagingmedicine.medical_specialtyContrast MediaColonoscopySensitivity and SpecificityInflammatory bowel diseaseChromoendoscopyDiagnosis DifferentialCrohn DiseasePredictive Value of TestsmedicineEndomicroscopyHumansMedical historyClinical Trials as TopicMicroscopy Confocalmedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingColonoscopyGeneral MedicineInflammatory Bowel Diseasesmedicine.diseaseMagnetic Resonance ImagingUlcerative colitisPositron emission tomographyPositron-Emission TomographyColitis UlcerativeRadiologyTomography X-Ray ComputedbusinessGastroentérologie Clinique et Biologique
researchProduct

5-Aminosalicylsäure-assoziierte Pankreatitis

2008

Acute pancreatitis with severe belt-like upper abdominal pain developed within 1-4 weeks of starting medication in three patients (29-year-old man with ulcerative colitis; 43-year-old woman and 22-year-old woman with Crohn's disease) treated, for the first time, with 5-aminosalicylic acid (mesalazine), 500 mg three times daily. Concentrations of lipase initially were 545, 1182 and 3000 U/l, and of amylase 243, 449 and 129 U/l, respectively. Symptoms receded within a few hours after the drug had been discontinued, enzyme levels returning to normal in the course of the next 2-3 weeks. On repeating the drug in two of the patients, in lower dosage, the pancreatitis recurred within a few days. T…

Drugmedicine.medical_specialtybiologybusiness.industrymedia_common.quotation_subjectGeneral Medicinemedicine.diseaseGastroenterologyUlcerative colitischemistry.chemical_compoundMesalazinechemistryInternal medicineUpper abdominal painbiology.proteinMedicinePancreatitisAcute pancreatitisAmylaseLipasebusinessmedia_commonDMW - Deutsche Medizinische Wochenschrift
researchProduct

Inflammatory Bowel Diseases

1979

The endoscopic aspects of an inflammatory colon disease do not permit the differentiation of a nonspecific proctitis from a bacterial enterocolitis and an ulcerative proctitis.

Enterocolitismedicine.medical_specialtybusiness.industryInflammatory Bowel DiseasesDiseasePseudomembranous colitismedicine.diseaseGastroenterologyUlcerative colitisdigestive system diseasesIschemic colitisUlcerative proctitisInternal medicineMedicinemedicine.symptombusinessProctitis
researchProduct

Elevated serum eotaxin levels in patients with inflammatory bowel disease.

2002

OBJECTIVE: Eotaxin is a recently characterized chemokine with potent and selective chemotactic activity for eosinophils. Previous studies indicating that eosinophils accumulate and become activated in inflammatory bowel disease (IBD) led us to hypothesize that eotaxin is potentially involved in the pathophysiology of IBD and, therefore, that eotaxin would be increased in the serum of patients with IBD. The objective of this study was to test those assumptions. METHODS: We investigated 72 patients with IBD, 35 with ulcerative colitis, and 37 with Crohn’s disease. A total of 27 patients had active and 45 inactive disease; 26 were receiving corticosteroids. Eotaxin serum levels were determined…

EotaxinAdultChemokine CCL11Adolescentmedicine.medical_treatmentInflammatory bowel diseaseSeverity of Illness IndexPathogenesisLeukocyte CountPrednisoneReference ValuesmedicineHumansAgedHepatologybusiness.industryGastroenterologyrespiratory systemEosinophilMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesPathophysiologyEosinophilsmedicine.anatomical_structureCytokineChemokines CCImmunologyColitis Ulcerativebusinessmedicine.drugThe American journal of gastroenterology
researchProduct

P114 A screening tool for the early diagnosis of extraintestinal manifestations in inflammatory bowel disease: the EMAIL questionnaire

2020

Abstract Background Data on prevalence of extraintestinal manifestations (EIMs) in inflammatory bowel disease (IBD) range from 6% up to 47%. Recently, several red flags and questionnaires have been proposed for early diagnosis of articular manifestations. Our aim was to analyse the prevalence of EIMs in a single-centre prospective cohort, using a comprehensive questionnaire developed by our group to detect all EIMs (EMAIL questionnaire). Methods Patients with IBD attending our Clinic from November 2017 to January 2019 were interviewed using a two-part questionnaire, the first part for clinical-demographic data and the second part for EIMs. Patients positive to screening were referred for mu…

Erythema nodosumAnkylosing spondylitismedicine.medical_specialtyCrohn's diseasebusiness.industryGastroenterologySacroiliitisGeneral Medicinemedicine.diseaseUlcerative colitisInflammatory bowel diseaseInternal medicinePsoriasismedicinebusinessPyoderma gangrenosumJournal of Crohn's and Colitis
researchProduct

Oral manifestations of gastrointestinal disorders

2017

Indexación: Scopus. Backgroud: A considerable number of gastrointestinal disorders (GIDs) of varied nature (inflammatory, infectious, genetic and other etiology) may produce alterations in the hard and soft oral tissues. Among these are Crohn's disease, ulcerative colitis, celiac and gastroesophageal reflux disease. Material and Methods: Article search was done using the National library of medicine (PubMed) database using different search terms and analyzed according to their importance. Results: A large variety of GIDs can give rise to oral lesions, including: RAS like ulceration, mucosal tags, cobblestoning, mucogingivitis, labial and facial swelling, pyostomatitis vegetans, disgeusia an…

Facial swellingmedicine.medical_specialtyOral lesionsSigns and symptomsReviewDiseaseGastrointestinal disorders03 medical and health sciences0302 clinical medicineQuality of lifeOral mucosal disordersmedicineGeneral DentistryOral Medicine and Pathologybusiness.industry030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ulcerative colitisDermatologystomatognathic diseasesSearch termsUNESCO::CIENCIAS MÉDICASEtiology030211 gastroenterology & hepatologymedicine.symptombusinessPyostomatitis vegetans
researchProduct

Beneficial Effect of Shikonin on Experimental Colitis Induced by Dextran Sulfate Sodium in Balb/C Mice

2012

[EN] The naphthoquinone shikonin, a major component of the root of Lithospermum erythrorhizon, now is studied as an anti-inflammatory agent in the treatment of ulcerative colitis (UC). Acute UC was induced in Balb/C mice by oral administration of 5% dextran sodium sulfate (DSS). The disease activity index was evaluated, and a histologic study was carried out. Orally administered shikonin reduces induced UC in a dose-dependent manner, preventing the shortening of the colorectum and decreasing weight loss by 5% while improving the appearance of feces and preventing bloody stools. The disease activity index score was much lower in shikonin-treated mice than in the colitic group, as well as the…

FarmacologiaArticle SubjectPolymorphonuclear leukocytesNF-KAPPA-BActivationIntestinal inflammationPharmacologyInflammatory bowel diseaseBALB/cchemistry.chemical_compoundExperimental Murine ColitisOral administrationWeight lossInflammatory-bowel-diseasemedicineAntisense oligonucleotideAcid-induced colitisbiologybusiness.industrylcsh:Other systems of medicineLithospermum erythrorhizonbiology.organism_classificationNFKB1medicine.diseaselcsh:RZ201-999Ulcerative colitisNaphthoquinoneComplementary and alternative medicinechemistryUlcerative-colitisImmunologyCytokinesmedicine.symptombusinessAntiinflamatorisResearch ArticleEvidence-Based Complementary and Alternative Medicine
researchProduct

Gene transfer approaches for the treatment of inflammatory bowel disease.

2003

The pathogenesis of Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease, involves a complex interplay between certain genetic, environmental and immunological factors. Considerable research progress in the last decade defined key inflammatory pathways in the inflamed gut and identified new potential therapeutic targets. Since the current medical treatment with corticosteroids and anti-inflammatory drugs is often associated with undesired side effects and cannot completely cure IBD, these current advances in our understanding of intestinal pathology may now allow the development of new biologic treatment strategies including gene therapy. In this review,…

Genetic enhancementGenetic VectorsGene ExpressionGene transferDiseaseInflammatory bowel diseaseAdenoviridaePathogenesisCrohn DiseaseIntestinal inflammationGeneticsMedicineAnimalsHumansMolecular BiologyMedical treatmentbusiness.industryBacterial InfectionsGenetic Therapymedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisIntestinesDisease Models AnimalImmunologyMolecular MedicineCytokinesColitis UlcerativeImmunotherapybusinessStem Cell TransplantationGene therapy
researchProduct

Association between previously identified disease loci at Chr 21q22 and MHC and UC in Italian population.

2009

GeneticsHepatologybiologybusiness.industryAssociation (object-oriented programming)Gastroenterologybiology.proteinMedicineUlcerative ColitisDiseasebusinessMajor histocompatibility complexItalian population
researchProduct